The relation between the effects of veratridine on action potential and contraction in mammalian ventricular myocardium.

Naunyn-Schmiedeberg's Archives of Pharmacology
P Honerjäger, M Reiter

Abstract

In the isolated papillary muscle of the guinea pig veratridine produces an increase of the force of contraction by increasing the rate of force development. Time to peak force is slightly reduced, whereas relaxation time is markedly prolonged. Threshold, half-maximally and maximally effective concentrations for the positive inotropic effect are 0.1, 0.4 and 1.6 muM, respectively. 2. The positive inotropic effect of the maximally effective concentration of veratridine amounts to 68% of the maximum positive inotropic effect of dihydro-ouabain tested on the same muscle (N = 12). 3. Veratridine prolongs the action potential (AP) by delaying repolarization. The effect is concentration-dependent (range: 0.4--3.2 muM); it requires 1--2 hrs of maintained exposure to reach a steady state and is only slowly reversible upon removal of the drug. A concentration causing a nearly maximal positive inotropic effect (0.8 muM) does not affect resting potential or rate of rise of the AP; the overshoot is slightly depressed. 4. Tetrodotoxin (5--16 muM) reversibly inhibits both AP prolongation and positive inotropic effect of veratridine by shifting the concentration-effect curves for these effects to higher concentrations of veratridine. It also p...Continue Reading

References

Oct 1, 1974·Physiological Reviews·T Narahashi
Jan 1, 1970·Physiological Reviews·A M Katz
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·M Reiter
Dec 19, 1973·Naunyn-Schmiedeberg's Archives of Pharmacology·P Honerjäger
Jul 31, 1973·Pflügers Archiv : European journal of physiology·M Horackova, G Vassort
Jan 1, 1974·Pflügers Archiv : European journal of physiology·M Horackova, G Vassort
Jun 1, 1974·Journal of Molecular and Cellular Cardiology·E Coraboeuf
Jan 1, 1972·Pflügers Archiv : European journal of physiology·W New, W Trautwein
Jan 1, 1971·Pflügers Archiv : European journal of physiology·M Vassalle, O Barnabei
Nov 1, 1971·The Journal of General Physiology·M Tarr
Mar 1, 1970·The Journal of Physiology·G W Beeler, H Reuter
Jan 1, 1969·The Journal of General Physiology·N Sperelakis, A J Pappano
Feb 1, 1969·The Journal of Physiology·P F BakerR A Steinhardt
Jun 25, 1966·Nature·R Howe, R G Shanks
May 1, 1958·Journal of Neurophysiology·G B FRANK
Jan 1, 1961·Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie·O KRAYER
May 29, 1964·Science·H S MOSHERH G FISCHER
Jun 30, 1952·Annals of the New York Academy of Sciences·A M SHANES
Jul 1, 1946·Physiological Reviews·O KRAYER, G H ACHESON

❮ Previous
Next ❯

Citations

May 31, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·M KorthM Reiter
Dec 29, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·U Ravens
Oct 6, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·P Honerjäger, M Reiter
Nov 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·P Honerjäger
Jul 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·M NodaK Ashida
Feb 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·P Honerjäger, A Meissner
Jul 22, 1983·European Journal of Pharmacology·P J Forshaw, J E Bradbury
Mar 2, 1984·European Journal of Pharmacology·J R BerlinF Matsumura
Jun 5, 1992·European Journal of Pharmacology·J LeboeufR Massingham
Jan 1, 1991·The International Journal of Biochemistry·R Moreno-Sánchez, R G Hansford
Jan 1, 1979·Toxicon : Official Journal of the International Society on Toxinology·R EndeanJ Surridge
Aug 1, 1997·Journal of Ethnopharmacology·H Y TsaiC F Chen
Sep 3, 1999·Journal of Ethnopharmacology·H Y TsaiY F Chen
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P K SieglG J Kaczorowski
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J H Jiao, A J Baertschi
Mar 24, 1998·Acta Anaesthesiologica Scandinavica·P J AdnetR M Krivosic-Horber
Oct 1, 1991·British Journal of Pharmacology·D WilhelmT Peters
Jan 1, 1989·Annals of the New York Academy of Sciences·R G HansfordB Lewartowski
Oct 1, 1982·Journal of Electrocardiology·M L Bhattacharyya, M Vassalle
Nov 1, 1988·British Journal of Pharmacology·A SeinoY Ohizumi
Jul 18, 2002·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Y F ChenH Y Tsai
Jan 1, 1983·Circulation Research·B W King, D Bose
Dec 1, 1991·Journal of Bioenergetics and Biomembranes·R G Hansford
Oct 1, 1987·Alcoholism, Clinical and Experimental Research·T N NguyenA M Mokraoui
Mar 1, 1996·Journal of Cardiovascular Pharmacology·Q LiU Ravens
Oct 1, 1984·The Anatomical Record·E F Fernández, R P Doel
Aug 20, 1981·Biochimica Et Biophysica Acta·S Yamamoto, K Greeff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pflügers Archiv : European journal of physiology
M Horackova, G Vassort
Pflügers Archiv : European journal of physiology
M Horackova, G Vassort
Naunyn-Schmiedeberg's Archives of Pharmacology
P Honerjäger, M Reiter
© 2022 Meta ULC. All rights reserved